LINC01180

Across TCGA pan-cancer cohorts, LINC01180 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC01180 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher LINC01180 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01180 expression acts as an unfavorable survival marker, although some lineages such as HNSC and BLCA show a favorable association.

CHOL, KIRC, and CESC are the cancer types where LINC01180 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.287	0.711	<.001	76	view →
KIRC	OS	Tertile	All	0.563	0.702	.002	70	view →
CESC	DFS	Tertile	III,IV	0.426	0.800	<.001	70	view →
MESO	OS	Median	IV	0.197	0.726	<.001	32	view →
LIHC	OS	Quartile	All	0.364	0.574	.002	28	view →
HNSC	OS	Quartile	All	0.839	0.732	.015	25	view →
BLCA	OS	Quartile	III,IV	0.606	0.335	.014	19	view →
DLBC	OS	Median	III,IV	0.272	1.000	.017	12	view →
THCA	DFS	Tertile	III,IV	0.853	0.958	.030	7	view →
SKCM	DFS	Tertile	IV	0.061	0.460	.046	6	view →
COAD	DFS	Tertile	III,IV	0.739	0.344	.042	6	view →
KIRP	DFS	Tertile	IV	0.658	0.363	.010	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC01180–CHOL (OS)

Open the CHOL breakdown →